Open company graph database — free web & API
Login

Innovacell Co., Ltd.

イノバセル株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
1
§01

Basic information

BASIC
Head office
5F, Meguro Villa Garden, 3-5-11 Kamiozaki, Shinagawa-ku, Tokyo 141-0021Sources
Chief executive
Nobick Corin, Seigar JasonSources
Capital
2,000,000
Employees (non-consolidated)
Employees (consolidated)
Start date
2021-01-05
End date
§02

Websites

1 DOMAINS
§03

Business

1
Development and manufacturing of regenerative medicine products targeting fecal incontinence and urinary incontinenceSources
§04

Related companies

1 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Innovacell Co., Ltd. Sources
Group Parent
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

18 EVENTS

Established Innovacell Biotechnologie GmbH in Innsbruck, AustriaSources

Obtained GMP certification for in-house manufacturing facilitiesSources

Changed corporate status from Innovacell Biotechnologie GmbH to Innovacell Biotechnologie AGSources

Changed corporate status from Innovacell Biotechnologie GmbH to Innovacell Biotechnologie AGSources

Completed Phase IIb trial of autologous skeletal muscle-derived cell product (ICES13) for abdominally induced urinary incontinenceSources

Completed Phase IIb trial of autologous skeletal muscle-derived cell product (ICEF15) for urge fecal incontinenceSources

Major shareholders changed from a group centered on European institutional investors to a group centered on our directorsSources

Implemented a triangular merger, becoming a wholly-owned subsidiary and changing the company name to Innovacell AGSources

Through the triangular merger, became the parent company of Innovacell AGSources

Established Innovacell Co., Ltd. with a capital of 20 million yenSources

Implemented a triangular merger, becoming a wholly-owned subsidiary and changing the company name to Innovacell AG. Through the triangular merger, became the parent company of Innovacell AGSources

Established on January 5, 2021, with a capital of 20 million yenSources

Established Innovacell Co., Ltd. with a capital of 20 million yenSources

Submitted a clinical trial notification for enrolling Japanese patients in the international Phase III trial of autologous skeletal muscle-derived cell product (ICEF15) for fecal incontinenceSources

Started enrolling European patients in the international Phase III trial of autologous skeletal muscle-derived cell product (ICEF15) for fecal incontinenceSources

Administered the product to the first patient in the international Phase III trial of autologous skeletal muscle-derived cell product (ICEF15) for fecal incontinenceSources

Started enrolling Japanese patients in the international Phase III trial of autologous skeletal muscle-derived cell product (ICEF15) for fecal incontinenceSources

Administered the first investigational product to a Japanese patient enrolled in the international Phase III trial of autologous skeletal muscle-derived cell product (ICEF15) for fecal incontinenceSources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information1011001137886
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
イノバセル株式会社
Trade name (kana)
イノバセル
Name in English
Corporation type
301
Address
〒141-0021 東京都品川区上大崎3丁目5番11号
Postal code
1410021
Prefecture code
13
City code
109
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2021-01-14
Update date
2023-10-19
Change date
2023-10-17
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
0
Trade name image ID
Address image ID
Sequence number
1347449
METI gBizINFO1011001137886
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
1011001137886
Trade name
イノバセル株式会社
Trade name (kana)
イノバセル
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都品川区上大崎3丁目5番11号
Postal code
1410021
Prefecture
東京都
Prefecture code
13
City or district
品川区
City code
109
Street address
上大崎3丁目5番11号
Organisation type
301
Processing type
12
Correction type
0
Status
Representative
代表取締役Co-CEO  ノビック・コーリン 代表取締役Co-CEO  シーガー・ジェイソン
Capital
4131360000
Employees
13
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2023-10-19
Key information
1011001137886
§09

Sources & updates

SOURCES
↑